Your browser doesn't support javascript.
loading
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Weinbergerová, Barbora; Demel, Ivo; Vísek, Benjamin; Válka, Jan; Cernan, Martin; Jindra, Pavel; Novák, Jan; Stejskal, Lukás; Kovácsová, Flóra; Kabut, Tomás; Szotkowski, Tomás; Hájek, Roman; Zák, Pavel; Cetkovský, Petr; Král, Zdenek; Mayer, Jirí.
Affiliation
  • Weinbergerová B; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Demel I; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Vísek B; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Válka J; Department of Haemato-oncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Cernan M; 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Jindra P; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Novák J; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
  • Stejskal L; Department of Haematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic.
  • Kovácsová F; Department of Internal Medicine and Haematology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Kabut T; Department of Hematology, Silesian Hospital in Opava, Opava, Czech Republic.
  • Szotkowski T; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Hájek R; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Zák P; Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Cetkovský P; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Král Z; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
  • Mayer J; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.
Hematol Oncol ; 40(2): 280-286, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35120267
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Clinical_trials / Observational_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Hematol Oncol Year: 2022 Document type: Article Affiliation country: Czech Republic Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Clinical_trials / Observational_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Hematol Oncol Year: 2022 Document type: Article Affiliation country: Czech Republic Country of publication: United kingdom